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(lead II or V5) for the VF group and controls. 39 
Figure 3: ST-segment morphology measured 100 ms after the J point (ST ≤ 0.0 mV, ST ≤ 0.05 mV, ST ≤ 40 
0.1 mV, and ST > 0.1 mV) and corresponding T-wave amplitudes in leads II and V5 for the 41 
ventricular fibrillation (VF) group and controls. 42 
Figure 4: Receiver operating characteristic curves for differentiating malignant from benign 43 
inferolateral early repolarization based on maximal J-wave amplitude, QTc interval, and lower 44 
T/R ratio (lead II or V5). AUC = area under receiver operating characteristic curve  45 
Figure 5: ECG examples of inferolateral early repolarization   46 
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ABSTRACT 47 
Background: Inferolateral early repolarization (ER) is highly prevalent and is associated with idiopathic 48 
ventricular fibrillation(VF). 49 
Objective: The purpose of this study was to evaluate the potential role of T-wave parameters to 50 
differentiate between malignant and benign ER. 51 
Methods: We compared the ECGs of patients with ER and VF (n = 92) with control subjects with 52 
asymptomatic ER (n = 247). We assessed J-wave amplitude, QTc interval, T-wave/R-wave (T/R) ratio 53 
in leads II and V5, and presence of low-amplitude T waves (T-wave amplitude < 0.1 mV and < 10% of 54 
R-wave amplitude in lead I, II, or V4–V6). 55 
Results: Compared to controls, the VF group had longer QTc intervals (388 ms vs 377 ms, P = .001), 56 
higher J-wave amplitudes (0.23 mV vs 0.17 mV, P <.001), higher prevalence of low-amplitude T waves 57 
(29% vs 3%, P <.001), and lower T/R ratio (0.18 vs 0.30, P <.001). Logistic regression analysis 58 
demonstrated that QTc interval (odds ratio [OR] per 10 ms: 1.15, 95% confidence interval [CI} 1.02–59 
1.30), maximal J-wave amplitude (OR per 0.1 mV: 1.68, 95% CI 1.23–2.31), lower T/R ratio (OR per 0.1 60 
unit: 0.62, 95% CI 0.47–0.81), presence of low-amplitude T waves (OR 3.53, 95% CI 1.26–9.88), and 61 
presence of J waves in the inferior leads (OR 2.58, 95% CI 1.18–5.65) were associated with malignant 62 
ER. 63 
Conclusions: Patients with malignant ER have a higher prevalence of low-amplitude T waves, lower 64 
T/R ratio (lead II or V5), and longer QTc interval. The combination of these parameters with J-wave 65 
amplitude and distribution of J waves may allow for improved identification of malignant ER. 66 
Keywords: J wave; Early repolarization; Ventricular fibrillation; Electrocardiogram; QT interval 67 
Abbreviations: CI = confidence interval; ECG = electrocardiogram; ER = early repolarization; OR = odds 68 
ratio; VF = ventricular fibrillation 69 
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INTRODUCTION 71 
The electrocardiographic (ECG) pattern of inferolateral early repolarization (ER) is common, with a 72 
particularly high prevalence reported among athletes and adolescents.1 An association between 73 
inferolateral ER with sudden cardiac arrest has been established by a number of different groups.2 74 
Population-based studies have also reported an increased mortality among patients with inferolateral 75 
ER compared to controls.1,3,4 Despite the reports linking ER with sudden death, only a small minority 76 
of patients with this pattern on the ECG will have sudden cardiac arrest, while the majority remain 77 
asymptomatic. The identification of this minority of patients represents a significant challenge. 78 
Currently, the identification of the malignant variant of the ER pattern is reliant on parameters such 79 
as the J-wave distribution, J-wave amplitude, and ST-segment morphology.5,6 However, the sensitivity 80 
and specificity of these parameters remain limited. Additionally, assessment of ST-segment 81 
morphology is difficult. The T wave may provide similar information as the ST-segment morphology 82 
measured at 100 ms after the J point, and other shave advocated analysis of repolarization markers 83 
independently of J-wave amplitude for risk stratification in inferolateral ER.7 Furthermore, the 84 
concomitant presence of inferolateral ER and long QT syndrome seems to increase arrhythmic risk.8,9 85 
In this study, we sought to determine the potential role of T-wave parameters to differentiate 86 
malignant and benign forms of inferolateral ER.  87 
  88 
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METHODS 89 
Study population 90 
Cases with ER and aborted sudden death were included from the International Registry of Idiopathic 91 
Ventricular Fibrillation, which has enrolled ventricular fibrillation (VF) patients from various tertiary 92 
care arrhythmia centers since January 2007.2 The diagnosis of idiopathic VF for patients included in 93 
the registry is based on the absence of identifiable structural heart disease (normal echocardiography) 94 
and detectable coronary artery disease (normal exercise testing or normal coronary angiography). 95 
Exclusion criteria for the registry include a corrected QT interval (QTc) <340 ms or >440 ms, 96 
spontaneous or drug-induced Brugada type1 ECG pattern, and catecholaminergic polymorphic 97 
ventricular arrhythmia. 98 
For the purposes of this study, we included patients with idiopathic VF with inferolateral ER (VF group) 99 
and an ECG of suitable quality for detailed analysis. The diagnosis of inferolateral ER was based on 100 
elevation of the QRS–ST junction (J point) by ≥0.1 mV above baseline in ≥2 contiguous inferior (II, III, 101 
aVF) and/or lateral leads (I, aVL, and V4–V6). The J-point elevation manifested as either QRS slurring or 102 
notching. A total of 92 patients from the registry fulfilled these criteria. Importantly, 8 patients with 103 
ER and idiopathic VF could not be included in the registry because of QTc >440 ms (n = 7; median QTc 104 
interval 470 ms, range 456–476 ms) or <340 ms (n = 1; QTc 310 ms). 105 
The control group consisted of subjects from the third Toulouse MONICA survey (n = 1171)10,11 and a 106 
subsample of the MONALISA study (study for Monitoring NAtionaL du rISque Artériel; n = 751).12,13 107 
The subjects of these studies were middle-aged men and women living in south-western France. They 108 
were randomly recruited from the general population. The objectives were to measure trends in 109 
cardiovascular mortality, coronary heart disease, and cerebrovascular disease morbidity.10,12,13 All 110 
subjects of these studies were included as controls irrespective of outcome during follow-up if they 111 
had inferolateral ER and an ECG of suitable quality for analysis (n = 250). One control subject with 112 
inferolateral ER was excluded because of QTc >440 ms (QTc 453 ms), and 2 control subjects were 113 
Published in final form edited form as: Heart Rhythm. 2016 Apr;13(4):894-902. doi: 10.1016/j.hrthm.2015.11.020 
excluded due to QTc <340 ms (QTc 336 ms and 332 ms, respectively). The final control group consisted 114 
of a total of 247 subjects. 115 
The study complies with the Declaration of Helsinki and was approved by the respective institutional 116 
review boards at all participating centers. 117 
 118 
ECG analysis 119 
All ECGs were digitized and analysed with a digital caliper (Iconico, Cardio Calipers, www.iconico.com). 120 
ECGs without a scale and those of low quality precluding any analysis were excluded. If several ECGs 121 
remained, ECGs recorded close to the arrhythmic event (usually within 1 week) were discarded. Of 122 
the remaining ECGs, the ECG with the highest J-wave amplitude was chosen for analysis. Median time 123 
from VF to the ECG chosen for analysis was 20 days. Heartrate, PR interval, QRS width, and QT interval 124 
were measured. The Bazett formula was used to correct QT interval for heart rate (QTc). 125 
Inferior (II, III, aVF), high lateral (I, aVL), and lateral (V4–V6) leads were analysed for the presence of J 126 
waves. Overall J-wave morphology was assessed as either only slurred J waves or any notched J wave 127 
(presence of only notched, or both notched and slurred J waves). In case of QRS slurring, the J-wave 128 
amplitude was measured at the point where slurring started to separate from the descending limb of 129 
the R wave and in case of QRS notching, at the top of the notch relative to the baseline. The baseline 130 
was defined as the isoelectric line between 2 T-P intervals. 131 
We analysed the ST segment 100 ms after the J point in leads II and V5 if a J wave was present in the 132 
respective lead. If the ST-segment amplitude was >0.1 mV, the ST segment was described as 133 
ascending/upsloping(ST >0.1 mV); if it was ≤0.1 mV, it was described as horizontal/descending (ST ≤0.1 134 
mV). If the ST segment showed a high take off at the J point and remained elevated >0.1 mV 100 ms 135 
after the J point, it also met the definition of ascending/upsloping. Additionally, we analysed whether 136 
the ST-segment amplitude was ≤0.05 mV (ST ≤0.05 mV) or ≤0.0 mV (ST ≤0.0 mV). 137 
We assessed all ECGs for the presence of low-amplitude T waves (dysmorphic T waves). A low-138 
amplitude T wave was defined as any T wave in lead I, II, or V4–V6 that was either inverted, biphasic, 139 
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or had an amplitude that was both ≤0.1 mV and ≤10% of the R-wave amplitude in the same lead. 140 
Amplitudes of R and T waves were measured in leads II and V5, and the T/R ratio was calculated 141 
separately for each lead (Figure 1). 142 
 143 
Statistical analysis 144 
Categorical variables are expressed as number and percentage and continuous variables as mean ± 145 
SD. Categorical variables were compared using the χ2 test or Fisher exact test and continuous variables 146 
with the unpaired t test. The Kolmogorov–Smirnov test with Lilliefors correction was used for 147 
normality testing of the QTc interval within each of the 2 groups. The sensitivity, specificity, positive 148 
and negative likelihood ratios, diagnostic odds ratios, and C statistics of various ECG parameters in 149 
differentiating malignant and benign inferolateral ER were calculated. Correlation analysis of ST-150 
segment morphology with T-wave amplitude was performed with the Spearman correlation 151 
coefficient (rs) and correlation analysis of R-wave amplitude with T-wave amplitude with the Pearson 152 
correlation coefficient (rp). The effect of age on QTc interval and lower T/R ratio (lead II or V5) was 153 
assessed with linear regression analysis. To assess the effect of age on maximal J-wave amplitude, the 154 
latter was dichotomized (≤0.2 mV vs 40.2 mV), and a binomial logistic regression analysis 155 
performed. A 2-way analysis of variance was performed to determine whether there was an 156 
interaction between groups and gender on QTc interval and lower T/R ratio (lead II or V5). To assess 157 
the interaction between groups and gender on maximal J-wave amplitude, a binomial logistic 158 
regression analysis was performed on the dichotomized variable (≤0.2 mV vs >0.2 mV). A binomial 159 
logistic regression was performed to ascertain the effect of QTc interval, maximal J-wave amplitude, 160 
lower T/R ratio (lead II or V5), presence of a dysmorphic T wave, and presence of J waves in the inferior 161 
leads on the likelihood of subjects being in the VF group. A 2-sided P <.05 was considered significant. 162 
All analyses were performed using SPSS 21.0 (SPSS Inc, Chicago, IL).  163 
 164 
 165 
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RESULTS 166 
Patients in the VF group were significantly younger than controls (37.1 ± 13.1 years vs 50.4 ± 10.9 167 
years, P<.001). In both groups, the majority were men (75% VF group vs 77% controls; P ± .71). Heart 168 
rate was significantly higher and QTc interval longer in the VF group compared to controls (Table 1). 169 
Of note, although the QTc interval was normally distributed in controls (P ± .20 according to the 170 
Kolmogorov–Smirnov test), this was not the case in the VF group (P ± .007; Figure 2). 171 
 172 
J wave 173 
ER was significantly more prevalent in the inferior leads in the VF group compared to controls (Table 174 
1). However, the prevalence was not different among the 2 groups in the high lateral and lateral leads. 175 
The maximal J-wave amplitude was significantly higher in the VF group (Table 1). Specifically, maximal 176 
J-wave amplitudes were higher in the inferior and lateral leads in the VF group but were not different 177 
in the high lateral leads.  178 
 179 
T wave 180 
Low-amplitude T waves were observed significantly more frequently in the VF group and very rarely 181 
in controls (Table 1). The T/R ratio in leads II and V5 was significantly lower in the VF group (Table 1). 182 
This was driven by a lower T-wave amplitude in lead V5 and by a combination of a lower T-wave 183 
amplitude and a higher R-wave amplitude in lead II. Figure 2 illustrates the dot plot of the lower T/R 184 
ratio (lead II or V5) for the 2 groups. 185 
 186 
ST segment 187 
The ST segment following the J wave in lead II was not different among groups. However, in lead V5 in 188 
the VF group the ST segment following the J wave was significantly less ascending (Table 1). Figure 3 189 
illustrates the correlation of different ST-segment morphologies (ST ≤0.0 mV, ST ≤0.05 mV, ST ≤0.1 190 
mV, ST >0.1 mV) with T-wave amplitude in lead II (VF group: rs = 0.54, P <.001; control group: rs = 0.48, 191 
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P <.001) and lead V5 (VF group: rs = 0.51, P <.001; control group: rs = 0.60, P <.001). R-wave amplitude 192 
correlated with T-wave amplitude in lead II (VF group: rp = 0.35, p = 0.001; control group: rp = 0.43, 193 
P <.001) and lead V5 (VF group: rp = 0.42, P <.001; control group: rp = 0.57, P <.001). 194 
 195 
Effect of age and gender 196 
Regression analysis did not demonstrate a significant effect of age on QTc interval, maximal J-wave 197 
amplitude (≤0.2 mV vs >0.2 mV), and lower T/R ratio (lead II or V5) for the VF group and controls (see 198 
Online Supplementary Table 1). 199 
The analysis also showed no statistically significant interaction between gender and group on QTc 200 
interval, maximal J-wave amplitude (≤0.2 mV vs >0.2 mV), and lower T/R ratio (lead II or V5) (see Online 201 
Supplementary Table 2). There was no statistically significant difference between males and females 202 
for maximal J-wave amplitude (≤0.2 mV vs >0.2 mV) and lower T/R ratio (lead II or V5). There was a 203 
statistically significant difference between males and females for QTc interval and between VF group 204 
and controls for QTc interval, maximal J-wave amplitude (≤0.2 mV vs >0.2 mV), and lower T/R ratio 205 
(lead II or V5). 206 
 207 
Best performing ECG parameters 208 
The lower T/R ratio (in either lead II or V5) was superior to lower T-wave amplitude (in either lead II or 209 
V5), maximal J\-wave amplitude, or QTc interval in differentiating malignant from benign ER (C statistic 210 
0.77, 0.68, 0.65, and 0.61, respectively; Figure 4). Table 2 demonstrates the performance of the 211 
various ECG parameters in terms of identification of malignant inferolateral ER. 212 
The logistic regression model was statistically significant [χ2 (5) = 85.218, P <.001; Table 3]. The model 213 
explained 32% (Nagelkerke R2) of the variance among groups and correctly classified 79% of all 214 
subjects. Sensitivity was 38%, and specificity was 94%. 215 
Some representative ECG examples of inferolateral ER in the VF group and in controls are shown in 216 
Figure 5. 217 
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DISCUSSION 218 
Patients with malignant inferolateral ER have longer QTc intervals, a higher prevalence of low-219 
amplitude T waves, and lower T/R ratios in leads II and V5 than controls with benign inferolateral ER. 220 
These T-wave parameters have superior performance in differentiating malignant from benign 221 
inferolateral ER than conventional ECG risk markers such as J-wave distribution, maximal J-wave 222 
amplitude, and ST-segment morphology. 223 
Multiple studies have reported that the presence of inferior or a combination of inferior and lateral J 224 
waves portends a higher arrhythmic risk compared to lateral J waves inisolation.1,3,4 Similarly, higher 225 
J-wave amplitudes have been associated with an increased risk of malignant arrhythmias.1–4 In keeping 226 
with these observations, we observed a higher prevalence of inferior J waves in the VF group 227 
compared to controls. We also observed higher maximal J-wave amplitudes in the VF group. Of note, 228 
however, control subjects also had a high prevalence of inferior J waves, and there was considerable 229 
overlap of maximal J-wave amplitudes between cases and controls. 230 
A horizontal/descending ST-segment morphology has also been reported to be a marker of increased 231 
arrhythmic risk in patients with inferolateral ER.5,6,11 Consistent with previous reports, we noted a less 232 
ascending ST-segment morphology in ER patients with VF compared to control subjects. However, the 233 
benign variant, which is characterized by an ascending ST-segment morphology (40.1 mV, 100 ms after 234 
the J point), was rare even among controls; therefore, its specificity is poor. We also analysed an 235 
intermediate form of ascending ST-segment morphology (40.05 mV, 100 ms after the J point). 236 
However, this did not improve the discriminatory performance of the ST-segment morphology. 237 
It is important to note that characterizing the ST-segment morphology has drawbacks. For instance, 238 
the definition is not uniform. There is no consensus as to whether only leads with a J wave should be 239 
assessed, whether the predominant pattern should be reported, or whether the observation of a 240 
horizontal ST-segment morphology in a single lead is sufficient to classify the pattern as malignant. 241 
Furthermore, it is difficult to assess whether ST-segment amplitude is 40.1 mV 100 ms after the J point. 242 
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In contrast to the drawbacks related to defining ST-segment morphology, measuring the T/R ratio is 243 
straight forward. A tall T wave usually is preceded by a more ascending ST-segment morphology. 244 
Accordingly, we observed a good correlation between ST-segment morphology and T-wave amplitude. 245 
As shown in our study, T-wave amplitude is also correlated to R-wave amplitude. Therefore, it seems 246 
reasonable to determine the relationship of the T-wave amplitude to the preceding R-wave amplitude. 247 
Compared to T-wave amplitude, the T/R ratio also demonstrated superior performance in 248 
differentiating malignant from benign inferolateral ER. Hence, ease of measurement and the 249 
possibility to correct the T-wave amplitude based on the R-wave amplitude are important advantages 250 
compared to ST-segment morphology. Therefore, we advocate the replacement of ST-segment 251 
morphology by lower T/R ratio (lead II or V5) for risk stratification in inferolateral ER. 252 
Another important finding of our study is a longer QTc interval among patients in the VF group, with 253 
an associated non gaussian distribution. More specifically, we observed several individuals with a QTc 254 
interval at the upper limit of normal in the VF group, whereas only a few control subjects had QTc 255 
intervals at the upper normal limit, eventhough controls were 2.5 times more numerous. This finding 256 
is reinforced by the fact that QTc interval 4440 ms was an exclusion criterion for our registry. 257 
Accordingly, 7 patients were not included in the registry because of QTc interval 4440 ms. In contrast, 258 
only 1 subject in the control group had to be excluded because of QTc interval 4440 ms, although the 259 
control group consisted of all patients within ferolateral ER from the French population-based 260 
MONICA survey and a subsample of the MONALISA study in southwestern France. Previous studies 261 
have reported that the QTc interval has anormal distribution in the general population. Consistent 262 
with these reports, the QTc intervals of our control cohort showed the expected Gaussian distribution 263 
(Figure 2). Compared to subjects without inferolateral ER, both healthy subjects with inferolateral ER 264 
14 and patients with malignant inferolateral ER15 have been reported to have shorter QTc intervals. In 265 
this study however, we compared QTc intervals among groups both having inferolateral ER and found 266 
longer QTc intervals in the VF group. Nevertheless, mean QTc intervals were rather short in both 267 
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groups (388 ms and 377 ms for VF group and controls, respectively) compared to published values in 268 
healthy controls without inferolateral ER; therefore, this finding is not contradictory.15 269 
In addition to studies linking ER in healthy subjects with an increased risk of malignant arrhythmia, 270 
multiple studies have reported that ER is a modulator of arrhythmic risk in patients with cardiac 271 
disease.16 In patients with long QT syndrome, the presence of inferolateral ER has been demonstrated 272 
to increase the probability of adverse events.9 In a Canadian registry of patients with apparently 273 
unexplained sudden cardiac arrest, further workup yielded a diagnosis in 44% of patients.8 Long QT 274 
syndrome was the most common diagnosis. Interestingly, the prevalence of inferolateral ER in this 275 
study was 23%, both in patients with long QT syndrome and in patients with idiopathic VF. Our findings 276 
provide further corroborating evidence implicating inferolateral ER as a modulator of risk in patients 277 
with subtle variations in QTc interval. Overall, our findings and those of others suggest that the 278 
concurrent presence of inferolateral ER and a QTc interval at the upper normal limit might be an 279 
ominous combination. 280 
According to our model, T-wave parameters such as the presence of dysmorphic T waves and a low 281 
T/R ratio (lead II or V5) are associated with malignant inferolateral ER. Additionally, QTc intervals at 282 
the upper limit of normal are rarely seen in controls with inferolateral ER. Therefore, we propose 283 
combining these T-wave parameters with the traditional parameters, that is, maximal J-wave 284 
amplitude and J-wave distribution, to enhance risk stratification in patients with inferolatera l ER. 285 
Depending on the clinical situation, one may choose different cut off values of those variables to have 286 
either a high sensitivity or a high specificity. 287 
 288 
STUDY LIMITATIONS 289 
Malignant inferolateral ER is a rare disease. Cases in this study are over represented, which may have 290 
affected the model. However, calculations of sensitivity and specificity typically are not affected by an 291 
incorrect representation of prevalence in case-control studies. The cases of our registry on idiopathic 292 
VF originate from multiple centers around the world. We have limited control on patients election in 293 
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both idiopathic VF patients and in the control population, which might have introduced some selection 294 
bias. Some patients in the VF group might have unrecognized, limited structural heart disease, which 295 
can be responsible for VF. On the other hand, structural heart disease and idiopathic VF maybe present 296 
in some control subjects. The QTc interval may have been overestimated in the VF group because of 297 
a higher heart rate in this group and under correction by the Bazett formula. Finally, the patients in 298 
the VF group were significantly younger than controls, although we did not detect an effect of age on 299 
the main variables investigated in this study. 300 
 301 
CONCLUSION 302 
Patients with malignant ER have a higher prevalence of low-amplitude T waves, lower T/R ratio (lead 303 
II or V5), and longer QTc interval, which lacks atypical gaussian distribution. Combining these 304 
parameters with maximal J-wave amplitude and presence of J waves in the inferior leads may allow 305 
for improved identification of malignant ER. 306 
 307 
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CLINICAL PERSPECTIVES 320 
Inferolateral early repolarization has a high prevalence but is also associated with ventricular 321 
fibrillation. Risk stratification remains challenging, especially in subjects with syncope or positive 322 
family history for sudden cardiac death. Traditional markers of malignant inferolateral early 323 
repolarization are J-wave amplitude, J-wave distribution, and horizontal ST- segment morphology, but 324 
performance of these markers is modest. This study puts the focus of risk stratification for malignant 325 
early repolarization on the T wave. It introduces the concept of dysmorphic T waves and T/R ratio in 326 
leads II and V5. Subjects with malignant inferolateral early repolarization have a higher prevalence of 327 
dysmorphic T waves, lower T/R ratio in leads II and V5, and longer QTc intervals compared to healthy 328 
controls with inferolateral early repolarization. These new markers, together with traditional marker 329 
so far rhythmic risk, may help improve risk stratification of inferolateral early repolarization. Before 330 
clinical application, the findings of this case-control study need further verification in large-scale 331 
population studies. 332 
 333 
SUPPLEMENTARY INFORMATION  334 
Supplementary data associated with this article can be found in the online version at 335 
http://dx.doi.org/10.1016/j.hrthm. 2015.11.020. 336 
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TABLES 385 
Table 1 386 
Baseline ECG characteristics. Values are given as mean ± SD or number (percent). VF = ventricular 387 
fibrillation. 388 
 389 
 390 
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Table 2  391 
Performance of various ECG parameters in differentiating malignant and benign inferolateral ER. CI = 392 
confidence interval; ER = early repolarization; +LR = positive likelihood ratio; -LR = negative likelihood 393 
ratio; OR = diagnostic odds ratio; SN = sensitivity; SP = specificity 394 
 395 
 396 
Table 3  397 
Binomial logistic regression model 398 
 399 
  400 
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FIGURES 401 
Figure 1  402 
Two examples showing how to calculate the T/R ratio 403 
 404 
 405 
 406 
Figure 2  407 
A: Bar graph showing the distribution of QTc interval (in milliseconds) for the ventricular fibrillation 408 
(VF)group (green bars) and controls (blue bars). B: Dot plot of the lower T/R ratio (lead II or V5) for the 409 
VF group and controls. 410 
 411 
           412 
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Figure 3  413 
ST-segment morphology measured 100 ms after the J point (ST ≤ 0.0 mV, ST ≤ 0.05 mV, ST ≤ 0.1 mV, 414 
and ST > 0.1 mV) and corresponding T-wave amplitudes in leads II and V5 for the ventricular fibrillation 415 
(VF) group and controls. 416 
 417 
 418 
  419 
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Figure 4 420 
Receiver operating characteristic curves for differentiating malignant from benign inferolateral early 421 
repolarization based on maximal J-wave amplitude, QTc interval, and lower T/R ratio (lead II or V5). 422 
AUC = area under receiver operating characteristic curve  423 
 424 
  425 
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Figure 5 426 
ECG examples of inferolateral early repolarization. ECGA: Ventricular fibrillation (VF) group (maximal 427 
J-wave amplitude 0.15 mV; no dysmorphic T waves; QTc 435 ms; lower T/R ratio 0.11 in lead V5). ECGB: 428 
VF group (maximal J-wave amplitude 0.47 mV; dysmorphic T wave in lead II; QTc 390 ms; lower T/R 429 
ratio 0.08 in lead II). ECG C: Control group (maximal J-wave amplitude 0.3 mV; no dysmorphic T waves; 430 
QTc 387 ms; lower T/R ratio 0.37 in lead II). ECG D: Control group (maximal J-wave amplitude 0.15 mV; 431 
no dysmorphic T waves; QTc 390 ms; lower T/R ratio 0.41 in lead II). 432 
 433 
